[1]
Ostrovskaya, O., Sips, M., Ulrichts, P., Trainor, L., Verheesen, P. and Stoykov, I. 2023. Efgartigimod: Clinical Development of a Novel FcRn Antagonist in the Treatment of Autoimmune Diseases. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s193. DOI:https://doi.org/10.25251/skin.7.supp.193.